Evidence map›Paper›PMID 36410256›Full record

ArticleAddictive behaviors2023

Longitudinal associations between receiving E-cigarette price promotions and subsequent E-cigarette use among U.S. Young adult cigarette smokers.

Maryam Elhabashy, Olivia A Wackowski, Melissa Mercincavage, Raul Cruz-Cano, Melissa H Abadi, Jenny E Ozga, Cassandra A Stanton, Julia Chen-Sankey

Open access · hybridAbstract read
In one paragraph

Article in Addictive behaviors, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed, 1 pooled it
0.6field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 1 synthesis or guideline pooled it, 5 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 6 institutions in 1 country.

Maryam ElhabashyCenter for Tobacco Studies, Rutgers Biomedical and Health Sciences, New Brunswick, NJ, United States.
Olivia A WackowskiCenter for Tobacco Studies, Rutgers Biomedical and Health Sciences, New Brunswick, NJ, United States; Rutgers School of Public Health, Rutgers University, Piscataway, NJ, United States.
Melissa MercincavageDepartment of Psychiatry, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, United States.
Raul Cruz-CanoIndiana University Bloomington School of Public Health, Bloomington, IN, United States.
Melissa H AbadiPacific Institute for Research & Evaluation, Louisville, KY, United States.
Jenny E OzgaBehavioral Health and Health Policy, Westat, Rockville, MD, United States.
Cassandra A StantonBehavioral Health and Health Policy, Westat, Rockville, MD, United States.
Julia Chen-SankeyCenter for Tobacco Studies, Rutgers Biomedical and Health Sciences, New Brunswick, NJ, United States; Rutgers School of Public Health, Rutgers University, Piscataway, NJ, United States. Electronic address: JC.Sankey@Rutgers.edu.
Rutgers, The State University of New Jersey · USWestat (United States) · USIndiana University Bloomington · USInstitute for Research and Evaluation · USRutgers HealthUniversity of Pennsylvania · US

Funding

TRANSCRIPTIONAL PROFILINGP30CA072720 · NCI · UNIV OF MED/DENT NJ-R W JOHNSON MED SCH · PI Chang S Chan · 1997 to 2026
$94.5M
Leadership and Logistics CoreU54DA046060 · NIDA · WESTAT, INC. · PI Jeanne Rosenthal · 2018 to 2026
$28.1M
Tobacco Industry Marketing CoreU54CA229973 · NCI · UNIVERSITY OF PENNSYLVANIA · PI STRASSER, ANDREW A · 2018 to 2022
$18.8M
Perceptions and Impact of Modified Risk Tobacco Product Communication MessagesR37CA222002 · NCI · RUTGERS BIOMEDICAL AND HEALTH SCIENCES · PI WACKOWSKI, OLIVIA · 2018 to 2023
$2.1M
Understanding the Influence of E-cigarette Advertisement FeaturesR00CA242589 · NCI · RUTGERS BIOMEDICAL AND HEALTH SCIENCES · PI CHEN-SANKEY, JULIA CEN · 2021 to 2024
$842k
NCI NIH HHS P30 CA072720NCI NIH HHS R00 CA242589NCI NIH HHS R37 CA222002NCI NIH HHS U54 CA229973NIDA NIH HHS U54 DA046060
6 · The paper itself

Abstract

introductionE-cigarette price promotions (EPPs; i.e., marketed reductions in cost) may influence young adult cigarette smokers to try, dual use with, or completely transition to e-cigarettes. We assessed whether receiving EPPs was associated with subsequent e-cigarette use among this group.

methodsData were from Waves 4 (2016-2018) and 5 (2018-2019) of the nationally representative Population Assessment of Tobacco and Health (PATH) Study survey. Analysis was restricted to participants who were young adult (18-34 years) established, current cigarette smokers who did not use e-cigarettes at Wave 4 (baseline; n = 2,664; Sample 1), and a subsample of those who tried to quit smoking completely in the past year at Wave 5 (follow-up; n = 948; Sample 2). Multivariable logistic regressions were used to examine associations between receiving EPPs at baseline and past year use of e-cigarettes in general (Sample 1) and to help quit smoking (Sample 2) at follow-up, controlling for covariates.

resultsOverall, 4.1% and 4.9% of Sample 1 and 2 participants received EPPs, respectively; At follow-up, 33.4% of Sample 1 participants used e-cigarettes, and 12.0% of Sample 2 participants used e-cigarettes to quit smoking. Receiving EPPs was associated with subsequent past-year e-cigarette use in general (AOR = 2.07; 95% CI = 1.31 to 3.27), and past-year e-cigarette use to help with quitting smoking (AOR = 3.20; 95% CI = 1.48 to 6.90). DISCUSSION: EPPs may increase e-cigarette use among established, current smokers and may be used to quit smoking. Research is needed to understand how EPPs may be differentially associated with complete product transition versus dual/poly use among young adult smokers.

Indexed as

Electronic Nicotine Delivery SystemsSmoking CessationTobacco ProductsVapingHumansSmokersSurveys and QuestionnairesYoung AdultCigarette smokingE-cigarettesHarm reductionPATH studyPrice promotionsSmoking cessationYoung adults

Identifiers

PMID36410256
PMCPMC9780183
OpenAlexW4308980542

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.